BridgeBio Pharma (BBIO)
(Delayed Data from NSDQ)
$28.73 USD
+1.03 (3.72%)
Updated May 9, 2024 04:00 PM ET
After-Market: $28.71 -0.02 (-0.07%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-0.98 | -8.79% |
Earnings Summary
For their last quarter, BridgeBio Pharma (BBIO) reported earnings of -$0.05 per share, beating the Zacks Consensus Estimate of $-0.40 per share. This reflects a positive earnings surprise of 87.50%. Look out for BBIO's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.98 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for BBIO
Dr. Reddy's (RDY) Q4 Earnings Top, North America Sales Grow
BBIO: What are Zacks experts saying now?
Zacks Private Portfolio Services